COVID-19
Far-UVC Light Kills 99.9% of Airborne Coronaviruses Within 25 Minutes in New Study
A new study has found that more than 99.9% of seasonal coronaviruses present in airborne droplets were killed when exposed to a particular wavelength of ultraviolet light that...
Latest COVID-19 News
- Scientists Identify Molecules with Unique Features that Shut Down SARS-Cov-2 Polymerase Reaction
- Moderna's Phase III COVID-19 Vaccine Trial Delayed
- COVID-19-Influenza Combination Test Granted FDA Emergency Use Authorization
- Transasia Launches COVID-19 IgG Antibody Kits with 98% Accuracy and at 20% Cost of RT-PCR Tests
- Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere
- Fluxergy Collaborates with Mass General Brigham to Evaluate One-Hour COVID-19 Diagnostic Test
- COVID-19 Infection Significantly Associated with Strokes, Find Researchers
- Tesla Building Portable, Automated “RNA Microfactories” for CureVac's COVID-19 Vaccine
- New Study Confirms COVID-19 Vaccine Will Need to Elicit T Cells to Work alongside Antibodies
- Fujifilm’s AI Platform, REiLI Chosen by ASST Vimercate Hospital to Support Operators in Fight Against COVID-19
- Eurofins Launches CE-IVD Marked Rapid POC Testing Devices to Identify Past Exposure to COVID-19 in 10 Minutes
- Pfizer and BioNTech Announce Early Positive Data from Phase 1/2 Study of mRNA-Based COVID-19 Vaccine Candidate
- T2 Biosystems Launches New COVID-19 Molecular Diagnostic Test
- FDA Issues Guidance to Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- Roche Secures FDA Emergency Use Authorization for Elecsys IL-6 Test to Identify Severe Inflammatory Response in COVID-19 Patients
- AI Platform Identifies 68 Genes Associated with High Risk of Severe COVID-19
- Revolutionary COVID-19 Patient Isolation Transport System Minimizes Infection Risk to Medical Personnel
- Nucleic-Acid Based COVID-19 Vaccine Candidate Generates Immune Responses in 94% of Phase 1 Trial Participants
- Interactive Data Visualization Tool Connects Scientists Worldwide with Vital COVID-19 Research Data
- Positive Clinical Data Supports Development of Single, Intranasal, Adjuvant-Free COVID-19 Vaccine Candidate
- Novel Interferon Inhalation Formulation Administered Through Nebulizer Could Reduce COVID-19 Severity
- Mutated Coronavirus in US and Europe 10 Times More Contagious Than Original Strain
- New Images Show for First Time How SARS-CoV-2 Dramatically Rewires Important Cell Programming
- Altimmune Receives Funding for Trial of Intranasal Candidate for Treatment of Outpatients with Early COVID-19
- New Online Tool Highlights Potential Future COVID-19 Virus Hotspots
- Blood Test Can Predict Severity of COVID-19
- Beckman Coulter's SARS-CoV-2 IgG Antibody Test Granted FDA Emergency Use Authorization
- Volunteers in Brazil Receive Oxford COVID-19 Vaccine in Latin America’s First Phase 3 Clinical Trial
- Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence